Triomics

Triomics

EHR data parsing with oncology LLMs

Overview

Triomics uses generative AI to turn unstructured health-record data in oncology into actionable insights. Its OncoLLM analyzes doctor notes, PDFs, and lab results to extract relevant clinical information, with Prism automating patient-to-clinical-trial matching and Harmony curating EHR data for quality reporting and cohort analysis. By integrating with existing EHR systems, it speeds up tasks that used to require hours of manual review and can match patients to trials in minutes with high accuracy. The goal is to reduce manual data review in cancer research and care, accelerate trial enrollment, and support precision oncology for cancer centers, academic medical centers, and health systems.

YC Company

About Triomics

Simplify's Rating
Why Triomics is rated
C+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$54.2M

Headquarters

New York City, New York

Founded

2020

People at Triomics

People at Triomics who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Triomics increased clinical trial matches by 40% and enrollments by over 30% at partner centers like Memorial Sloan Kettering.
  • OncoLLM reduces chart review time by 67% and operates at $170/hour versus $6,055/hour for GPT-4.
  • Triomics expanded automation to include the industry’s first full-stack cancer registry solution via partnership with Savista.

What critics are saying

  • Mount Sinai may develop its own oncology AI within 12–18 months, creating direct competition with 35–50% probability.
  • Regenstrief Institute’s real-world evaluation could reveal accuracy gaps in Prism, undermining Triomics’ 90% matching claim with 40–60% probability.
  • OncoLLM’s 14B parameters fine-tuned on single-center data risk catastrophic degradation when scaled to diverse EHRs with 50–70% probability.

What makes Triomics unique

  • Triomics uses OncoLLM to reason across hundreds of pages per patient record instead of page-by-page parsing.
  • Its PRISM tool matches patients to clinical trials with 95% accuracy at the top-3 level, validated by experts.
  • Triomics integrates natively with major EHRs like Epic and OncoEMR, delivering structured, cited outputs directly into workflows.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$54.2M

Meets

Industry Average

Funded Over

5 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Below Average

Industry standards

$35M
$30M
Patreon
$45M
Linktree
$65M
Substack
$100M
ClickUp

Benefits

Health Insurance

Flexible Work Hours

Meal Benefits

Growth & Insights

Headcount

6 month growth

-1%

1 year growth

-7%

2 year growth

-1%

Recently Posted Jobs

Sign up to get curated job recommendations

Triomics is Hiring for 12 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →